Difference between revisions of "Test"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 6: | Line 6: | ||
**sub division | **sub division | ||
***sub-sub-sub division | ***sub-sub-sub division | ||
| + | |||
| + | |||
| + | |||
| + | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities]] | ||
| + | |||
| + | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] | ||
| + | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] | ||
| + | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1]] | ||
| + | |||
| + | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes]] | ||
| + | |||
| + | *[[Therapy-Related Myeloid Neoplasms]] | ||
| + | |||
| + | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified]] | ||
| + | |||
| + | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation]] | ||
| + | - [[Acute Myeloid Leukemia (AML) without Maturation]] | ||
| + | - [[Acute Myeloid Leukemia (AML) with Maturation]] | ||
| + | - [[Acute Myelomonocytic Leukemia]] | ||
| + | - [[Acute Monoblastic and Monocytic Leukemia]] | ||
| + | - [[Pure Erythroid Leukemia]] | ||
| + | - [[Acute Megakaryoblastic Leukemia (AMKL)]] | ||
| + | - [[Acute Basophilic Leukemia]] | ||
| + | - [[Acute Panmyelosis with Myelofibrosis]] | ||
| + | |||
| + | *[[Myeloid Sarcoma]] | ||
| + | |||
| + | *[[Myeloid Proliferations Associated with Down Syndrome]] | ||
| + | |||
| + | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] | ||
| + | - [[Myeloid Leukemia Associated with Down Syndrome]] | ||
| + | |||
| + | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | ||
| + | |||
| + | *[[Acute Leukemias of Ambiguous Lineage]] | ||
| + | |||
| + | - [[Acute Undifferentiated Leukemia]] | ||
| + | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] | ||
| + | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] | ||
| + | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] | ||
| + | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] | ||
| + | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] | ||
| + | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | ||
| + | |||
| + | *[[Myeloid Neoplasms with Germline Predisposition]] | ||
| + | |||
| + | - [[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | ||
| + | - [[Myeloid Neoplasms with Germline DDX41 Mutation]] | ||
| + | - [[Myeloid Neoplasms with Germline RUNX1 Mutation]] | ||
| + | - [[Myeloid Neoplasms with Germline ANKRD26 Mutation]] | ||
| + | - [[Myeloid Neoplasms with Germline ETV6 Mutation]] | ||
| + | - [[Myeloid Neoplasms with Germline GATA2 Mutation]] | ||
Revision as of 15:23, 14 February 2021
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms
- Recurrent Genetic Abnormalities
- t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
- sub division
- sub-sub-sub division
- sub division
- Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - Acute Promyelocytic Leukemia (APL) with PML-RARA - Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 - Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 - Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM - Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 - Acute Myeloid Leukemia (AML) with BCR-ABL1 - Acute Myeloid Leukemia (AML) with Mutated NPM1 - Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA - Acute Myeloid Leukemia (AML) with Mutated RUNX1
- Acute Myeloid Leukemia (AML) with Minimal Differentiation - Acute Myeloid Leukemia (AML) without Maturation - Acute Myeloid Leukemia (AML) with Maturation - Acute Myelomonocytic Leukemia - Acute Monoblastic and Monocytic Leukemia - Pure Erythroid Leukemia - Acute Megakaryoblastic Leukemia (AMKL) - Acute Basophilic Leukemia - Acute Panmyelosis with Myelofibrosis
- Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome - Myeloid Leukemia Associated with Down Syndrome
- Acute Undifferentiated Leukemia - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)
- Acute Myeloid Leukaemia with Germline CEBPA Mutation - Myeloid Neoplasms with Germline DDX41 Mutation - Myeloid Neoplasms with Germline RUNX1 Mutation - Myeloid Neoplasms with Germline ANKRD26 Mutation - Myeloid Neoplasms with Germline ETV6 Mutation - Myeloid Neoplasms with Germline GATA2 Mutation